Related Experiment Video
Updated: Nov 22, 2025
07:46
Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
Published on: October 15, 2010
44.1K
Smoking status and endothelial function in Japanese men.
Haruki Hashimoto1, Tatsuya Maruhashi1, Takayuki Yamaji1
1Department of Cardiovascular Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Scientific Reports
|January 9, 2021
Summary
Heavy smoking significantly impairs endothelial function, a key factor in atherosclerosis development. This study shows that greater smoking intensity correlates with reduced flow-mediated vasodilation (FMD) in men.
Area of Science:
- Cardiovascular Research
- Vascular Biology
- Public Health
Background:
- Smoking is a primary risk factor for atherosclerosis.
- Endothelial dysfunction is an early and critical step in atherosclerosis development.
Purpose of the Study:
- To comprehensively assess the relationship between smoking status and endothelial function in men.
- To investigate how different levels of smoking, measured in pack-years, impact vascular health.
Main Methods:
- Flow-mediated vasodilation (FMD) was measured in 2209 Japanese men.
- Participants were categorized into five smoking groups: never, light, moderate, heavy, and excessive smokers based on pack-years.
- Statistical analyses adjusted for age, BMI, blood pressure, cholesterol, glucose, and recruitment year.
Main Results:
- FMD showed a significant inverse correlation with smoking pack-years.
- Excessive smokers exhibited significantly lower FMD compared to never smokers, even after adjusting for multiple cardiovascular risk factors.
- A dose-dependent relationship was observed, with increased smoking correlating to decreased FMD.
Conclusions:
- Increased cigarette consumption is linked to diminished endothelial function.
- Excessive smoking is strongly associated with endothelial dysfunction in men.
- Cigarette smoking poses a significant threat to vascular health, particularly in heavy smokers.
More Related Videos
Related Concept Videos
01:26Coronary Artery Disease II: Pathophysiology
191
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
191
01:26Atherosclerosis III: Management
136
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
136
01:30Coronary Artery Disease I: Introduction
672
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
672